Atossa Therapeutics Inc
NASDAQ:ATOS
Income Statement
Earnings Waterfall
Atossa Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-31.4m
USD
|
Operating Income
|
-31.4m
USD
|
Other Expenses
|
1.3m
USD
|
Net Income
|
-30.1m
USD
|
Income Statement
Atossa Therapeutics Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
1
N/A
|
0
-25%
|
0
-67%
|
0
-50%
|
0
-50%
|
0
-75%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gross Profit |
0
N/A
|
0
-34%
|
0
-47%
|
0
-50%
|
0
-20%
|
0
-75%
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(2)
-1 508%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(11)
|
(11)
|
(12)
|
(12)
|
(10)
|
(13)
|
(13)
|
(14)
|
(13)
|
(15)
|
(10)
|
(8)
|
(7)
|
(7)
|
(8)
|
(8)
|
(7)
|
(8)
|
(10)
|
(11)
|
(11)
|
(14)
|
(17)
|
(17)
|
(17)
|
(16)
|
(13)
|
(13)
|
(15)
|
(15)
|
(18)
|
(20)
|
(21)
|
(22)
|
(21)
|
(24)
|
(28)
|
(30)
|
(31)
|
(31)
|
(31)
|
|
Selling, General & Administrative |
(10)
|
(10)
|
(10)
|
(9)
|
(9)
|
(9)
|
(10)
|
(10)
|
(10)
|
(10)
|
(8)
|
(7)
|
(6)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(7)
|
(7)
|
(7)
|
(8)
|
(10)
|
(10)
|
(11)
|
(10)
|
(8)
|
(8)
|
(8)
|
(8)
|
(9)
|
(10)
|
(11)
|
(12)
|
(12)
|
(12)
|
(13)
|
(13)
|
(14)
|
(14)
|
(14)
|
|
Research & Development |
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(5)
|
(6)
|
(7)
|
(7)
|
(6)
|
(5)
|
(5)
|
(7)
|
(7)
|
(9)
|
(10)
|
(9)
|
(9)
|
(9)
|
(12)
|
(15)
|
(17)
|
(17)
|
(17)
|
(17)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(2)
|
0
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(11)
N/A
|
(11)
-4%
|
(12)
-7%
|
(12)
+2%
|
(10)
+15%
|
(13)
-33%
|
(13)
+0%
|
(14)
-5%
|
(13)
+6%
|
(12)
+7%
|
(10)
+14%
|
(8)
+22%
|
(7)
+8%
|
(7)
-1%
|
(8)
-5%
|
(8)
-7%
|
(7)
+12%
|
(8)
-9%
|
(10)
-29%
|
(11)
-12%
|
(11)
-1%
|
(14)
-19%
|
(17)
-23%
|
(17)
+0%
|
(17)
-3%
|
(16)
+6%
|
(13)
+21%
|
(13)
-2%
|
(15)
-12%
|
(15)
-4%
|
(18)
-20%
|
(20)
-9%
|
(21)
-3%
|
(22)
-6%
|
(21)
+2%
|
(24)
-14%
|
(28)
-14%
|
(30)
-9%
|
(31)
-4%
|
(31)
+2%
|
(31)
-3%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
1
|
2
|
3
|
4
|
4
|
|
Non-Reccuring Items |
(0)
|
(0)
|
0
|
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(3)
|
(3)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(3)
|
(3)
|
(3)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Pre-Tax Income |
(11)
N/A
|
(11)
-4%
|
(12)
-5%
|
(12)
+2%
|
(12)
-5%
|
(13)
-7%
|
(13)
+1%
|
(13)
-4%
|
(13)
+5%
|
(12)
+7%
|
(10)
+12%
|
(6)
+38%
|
(6)
+1%
|
(6)
+10%
|
(6)
-9%
|
(9)
-38%
|
(8)
+6%
|
(8)
-2%
|
(10)
-23%
|
(11)
-11%
|
(11)
-1%
|
(14)
-19%
|
(17)
-23%
|
(17)
+0%
|
(17)
-3%
|
(16)
+6%
|
(13)
+21%
|
(13)
-2%
|
(18)
-37%
|
(18)
-3%
|
(22)
-17%
|
(23)
-8%
|
(21)
+11%
|
(22)
-6%
|
(21)
+2%
|
(24)
-13%
|
(27)
-11%
|
(28)
-6%
|
(32)
-11%
|
(30)
+6%
|
(30)
-1%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(11)
|
(11)
|
(12)
|
(12)
|
(12)
|
(13)
|
(13)
|
(13)
|
(13)
|
(12)
|
(10)
|
(6)
|
(6)
|
(6)
|
(6)
|
(9)
|
(8)
|
(8)
|
(10)
|
(11)
|
(11)
|
(14)
|
(17)
|
(17)
|
(17)
|
(16)
|
(13)
|
(13)
|
(18)
|
(18)
|
(22)
|
(23)
|
(21)
|
(22)
|
(21)
|
(24)
|
(27)
|
(28)
|
(32)
|
(30)
|
(30)
|
|
Net Income (Common) |
(11)
N/A
|
(11)
-4%
|
(12)
-5%
|
(12)
+2%
|
(15)
-26%
|
(16)
-6%
|
(16)
+0%
|
(17)
-7%
|
(16)
+5%
|
(15)
+6%
|
(13)
+10%
|
(9)
+34%
|
(6)
+28%
|
(6)
+10%
|
(9)
-54%
|
(11)
-27%
|
(11)
+5%
|
(11)
-1%
|
(22)
-100%
|
(23)
-5%
|
(23)
0%
|
(25)
-10%
|
(17)
+33%
|
(17)
+0%
|
(17)
-3%
|
(16)
+6%
|
(13)
+21%
|
(13)
-2%
|
(22)
-72%
|
(23)
-3%
|
(26)
-14%
|
(28)
-7%
|
(21)
+26%
|
(22)
-6%
|
(21)
+2%
|
(24)
-13%
|
(27)
-11%
|
(28)
-6%
|
(32)
-11%
|
(30)
+6%
|
(30)
-1%
|
|
EPS (Diluted) |
-107.79
N/A
|
-80.35
+25%
|
-84.71
-5%
|
-82.92
+2%
|
-112.76
-36%
|
-111.35
+1%
|
-103.66
+7%
|
-110.8
-7%
|
-98.5
+11%
|
-73.8
+25%
|
-47.6
+36%
|
-35.24
+26%
|
-25.48
+28%
|
-17.94
+30%
|
-14.01
+22%
|
-10.88
+22%
|
-11.02
-1%
|
-4.09
+63%
|
-7.05
-72%
|
-4.39
+38%
|
-5.5
-25%
|
-3.81
+31%
|
-1.83
+52%
|
-1.82
+1%
|
-2.03
-12%
|
-1.77
+13%
|
-1.4
+21%
|
-1.27
+9%
|
-1.97
-55%
|
-0.24
+88%
|
-0.21
+13%
|
-0.21
N/A
|
-0.18
+14%
|
-0.18
N/A
|
-0.17
+6%
|
-0.19
-12%
|
-0.21
-11%
|
-0.22
-5%
|
-0.25
-14%
|
-0.24
+4%
|
-0.24
N/A
|